With Prof. Ronjon Nag OBE, re.comm 26 welcomes an internationally renowned AI pioneer, entrepreneur, and longevity expert to Kitzbühel. In his presentation , “AI, the Aging Vaccine, and the Century Ahead,” he focuses on a development that could extend far beyond medicine and technology: the question of how artificial intelligence can help combat diseases earlier and significantly extend human healthspan.
Ronjon Nag is the founder and CEO of Agemica, founder and president of the R42 Group, and an adjunct professor of genetics at the Stanford School of Medicine. For decades, he has been working on artificial intelligence and its applications in the life sciences. His current work focuses in particular on biotechnology, longevity, and the development of new approaches that could harness the immune system to combat diseases and age-related changes.
Can a vaccine affect the aging process?
His presentation begins with a discussion of recent advances in personalized mRNA vaccines against cancer. Ronjon Nag takes this a step further and asks whether vaccine platforms could be developed in the future that target not only specific diseases but also biological characteristics common to various types of cancer and the aging process.
In doing so, he clearly explains the role that artificial intelligence plays in the development of such approaches, what insights are already available, and where the scientific, clinical, and regulatory limitations lie.
When Longer Life Spans Transform the Economy and Society
The potential implications extend far beyond the healthcare sector. If people live healthy lives for decades longer in the future, this will also transform demographics, cities, real estate, pension systems, capital markets, and career paths. Companies would have to plan over longer time frames, investment horizons would shift, and the demands placed on cities, housing models, and communities could also change fundamentally.
It is precisely this combination of technological progress, far-reaching opportunities, and new strategic challenges that makes Ronjon Nag’s perspective particularly relevant to the central theme of re.comm 26: “The Age of Disruption – Strategic Decision Making Between Innovation, Risk, and Global Volatility.”
With his presentation, Ronjon Nag offers a glimpse into a future in which artificial intelligence will not only transform business models and industries, but may also redefine how long and how healthily people live.
